TERN vs TPR · $6.12B cap vs P/E 46, rev $8.00B
Terns Pharmaceuticals Inc (TERN) versus Tapestry Inc (TPR) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Tapestry Inc (TPR) is a luxury goods company listed on NYSE.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported TPR revenue for 2026-06-27 was $8.00B. Net income was $1.53B. Revenue was up 14.2% from 2025-06-28 to 2026-06-27. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
TERN currently screens at market cap $6.12B. TPR currently screens at market cap $30.81B and trailing P/E 46.3.
Not investment advice. Open the TERN and TPR stock pages for the full models.
Not investment advice.